Log in
RegisterErythromycin Ethylsuccinate Tablet [Regulatives / Guidelines]
Dear Team,
Query is with reference to Erythromycin Ethylsuccinate Tablet BE study Submission to US FDA
For Erythromycin Ethylsuccinate whether there are any literature evidences to provide that it is Highly variable drug.
Also, as per current OGD BE recommendation bioequivalence to be established based on Erythromycin Ethylsuccinate. But Erythromycin Ethylsuccinate is unstable in plasma and rapidly hydrolyzed to Erythromycin. Measuring analyte as erythromycin Ethylsuccinate will not give reliable result. Instead of Erythromycin Ethylsuccinate total Erythromycin to be measured. Can you please provide comments on this aspect?
With regards
AB661
Query is with reference to Erythromycin Ethylsuccinate Tablet BE study Submission to US FDA
For Erythromycin Ethylsuccinate whether there are any literature evidences to provide that it is Highly variable drug.
Also, as per current OGD BE recommendation bioequivalence to be established based on Erythromycin Ethylsuccinate. But Erythromycin Ethylsuccinate is unstable in plasma and rapidly hydrolyzed to Erythromycin. Measuring analyte as erythromycin Ethylsuccinate will not give reliable result. Instead of Erythromycin Ethylsuccinate total Erythromycin to be measured. Can you please provide comments on this aspect?
With regards
AB661
Complete thread:
- Erythromycin Ethylsuccinate TabletAB661 2025-04-02 11:39 [Regulatives / Guidelines]
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Erythromycin Ethylsuccinate Tablet dshah 2025-04-10 05:19
Ing. Helmut Schütz